STOCK TITAN

CLEVER LEAVES HLDGS INC - CLVR STOCK NEWS

Welcome to our dedicated page for CLEVER LEAVES HLDGS news (Ticker: CLVR), a resource for investors and traders seeking the latest updates and insights on CLEVER LEAVES HLDGS stock.

Clever Leaves Holdings Inc. (symbol: CLVR) is a pioneering company in the medical cannabis industry, headquartered in Colombia. As one of the first Colombian license holders in this field, Clever Leaves has established a robust market presence through its expansive cultivation and extraction operations. By 2023, the company aims to become the world’s largest grower, with over 10 million square feet of cultivation capacity. It also plans to be the largest extractor with pharmaceutical-grade and GMP-certified processing facilities, achieving the lowest cost in cannabis exports globally.

Clever Leaves operates with a differentiated business model that focuses on medical cannabis. They have strategically positioned themselves to lead the global market, bolstering their reputation among regulators, physicians, and key industry stakeholders. The company's significant achievements include launching major cultivation projects and building strong international partnerships.

The company is developing crucial capabilities to excel in the medical cannabis industry, backed by a highly experienced and respected team. Clever Leaves has continuously demonstrated its commitment to quality and compliance, ensuring that all its products meet the highest pharmaceutical standards.

Recent updates include the cessation of production operations in Portugal, which has been classified as discontinued operations as of March 31, 2023. This decision reflects Clever Leaves' focus on optimizing its operational efficiency and financial performance. The company regularly hosts conference calls to keep investors and stakeholders informed about its latest developments and financial status.

For more detailed information or inquiries, investors can reach out to the company's commercial and press contacts:

  • Maria Petsanas / Anne Donohoe, KCSA Strategic Communications, cleverleaves@kcsa.com, +1 917-692-6673
  • Andrew Miller, Head of Global Business Development, Andrew.miller@cleverleaves.com, +1 416-817-1336
  • Julian Wilches, Chief Regulatory Officer, Co-Founder, Julian.wilches@cleverleaves.com, +1-305-927-6642
Rhea-AI Summary

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) announced a voluntary delisting and SEC deregistration of its common shares and warrants from Nasdaq to terminate reporting obligations. The last day of trading on Nasdaq is expected to be on or about May 16, 2024. The Company plans to suspend reporting obligations under the Exchange Act by filing a Form 15 with the SEC. The Board's decision was based on careful evaluation of factors including non-compliance with Nasdaq listing requirements and high regulatory costs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-60.58%
Tags
none
-
Rhea-AI Summary
Clever Leaves Holdings Inc. reported a 6% increase in revenue for 2023, driven by a 39% rise in full-year cannabinoid revenue. The company also achieved a 26% reduction in general and administrative expenses in Q4 2023 and a 24% reduction for the full year. Additionally, Clever Leaves completed the sale of its non-cannabinoid herbal brands business for $8.02 million, enhancing its focus on the cannabinoid segment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
-
Rhea-AI Summary
Clever Leaves Holdings Inc. partners with Paradise Seeds to develop and register high-performance cannabis cultivars in Colombia, aiming to expand its global footprint. This collaboration marks the first agronomic registrations of Paradise genetics in Colombia, enabling licensed cultivation and production of Paradise strains for export to global medicinal cannabis markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.09%
Tags
none
Rhea-AI Summary
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global medicinal cannabis company, has been granted Australian GMP certification by the TGA for the manufacturing of cannabis products in Colombia. This makes Clever Leaves the first and only medicinal cannabis company globally with GMP certifications from the European Union, Colombia, Brazil, and Australia.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.48%
Tags
none
-
Rhea-AI Summary
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) reports Q3 revenue increase of 33% YoY, driven by 135% YoY growth in cannabinoid revenue. Adjusted EBITDA improved YoY to $(2.6) million. Cash balance at October 31, 2023, was $6.2 million. Updated full-year 2023 guidance reflects revenue timing shifts and adjusted EBITDA improvement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.5%
Tags
-
Rhea-AI Summary
Clever Leaves Holdings Inc. will hold a conference call on November 9, 2023, to discuss its Q3 2023 financial results. The call will be hosted by Clever Leaves management and will include a question-and-answer session. The conference call will be broadcast live and available for replay. Toll-free and international dial-in numbers are provided.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.6%
Tags
Rhea-AI Summary
Clever Leaves regains compliance with Nasdaq minimum bid price requirement
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.13%
Tags
none
-
Rhea-AI Summary
Clever Leaves awarded International Declaration of Carbon Neutrality for commitment to sustainability
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.19%
Tags
none
-
Rhea-AI Summary
Clever Leaves approves 1-for-30 reverse split of common shares
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.66%
Tags
none
Rhea-AI Summary
Clever Leaves reports 21% YoY revenue growth, driven by 151% YoY growth in cannabinoid revenue. Expense reductions lead to improved Adjusted EBITDA performance of ($2.1) million. Sale of Portuguese processing assets adds $2.7 million in cash. Reaffirms 2023 guidance: revenue $19-22M, adjusted gross margin 58-63%, adjusted EBITDA $(13.6)-(10.6)M.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.67%
Tags

FAQ

What is the current stock price of CLEVER LEAVES HLDGS (CLVR)?

The current stock price of CLEVER LEAVES HLDGS (CLVR) is $0.000001 as of October 15, 2024.

What is the market cap of CLEVER LEAVES HLDGS (CLVR)?

The market cap of CLEVER LEAVES HLDGS (CLVR) is approximately 5.3M.

What is Clever Leaves Holdings Inc.?

Clever Leaves Holdings Inc. (CLVR) is a leading company in the medical cannabis industry, headquartered in Colombia. It focuses on cultivation and extraction of cannabis with pharmaceutical-grade and GMP-certified facilities.

Where is Clever Leaves located?

Clever Leaves is headquartered in Colombia, with operations extending globally.

What are Clever Leaves' main products?

Clever Leaves produces medical-grade cannabis products, focusing on high-quality cultivation and extraction processes.

What is the cultivation capacity of Clever Leaves?

By 2023, Clever Leaves aims to have over 10 million square feet of cultivation capacity, making it the world’s largest grower.

What recent changes has Clever Leaves undergone?

Clever Leaves has discontinued its production operations in Portugal as of March 31, 2023, to optimize efficiency and financial performance.

How does Clever Leaves ensure product quality?

Clever Leaves adheres to pharmaceutical-grade standards and GMP-certified processes to ensure high-quality products.

Who are the key contacts at Clever Leaves?

Key contacts include Maria Petsanas and Anne Donohoe from KCSA Strategic Communications, Andrew Miller, Head of Global Business Development, and Julian Wilches, Chief Regulatory Officer and Co-Founder.

How can investors get updates about Clever Leaves?

Investors can participate in the regular conference calls hosted by Clever Leaves or contact their press and commercial representatives for more information.

What industry is Clever Leaves involved in?

Clever Leaves operates in the medical cannabis industry, focusing on cultivation and extraction.

What sets Clever Leaves apart in the cannabis industry?

Clever Leaves stands out due to its large-scale cultivation capacity, pharmaceutical-grade processing, global partnerships, and commitment to quality and compliance.

CLEVER LEAVES HLDGS INC

Nasdaq:CLVR

CLVR Rankings

CLVR Stock Data

5.26M
1.22M
30.75%
2.31%
2.02%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
TOCANCIPA - CUNDINAMARCA